GAMP is a technical subcommittee of ISPE. It produces guidance documents to aid the pharmaceutical industry in validating computerized systems to ensure they are fit for their intended use and compliant with regulatory requirements (such as FDA 21 CFR Part 11 and EU Annex 11).
While GAMP 4 was revolutionary, it was often criticized for fostering a "check-the-box" mentality that prioritized paperwork over actual product quality. This led to the release of in 2008, which shifted the industry toward a risk-based, flexible lifecycle approach . Key transitions from GAMP 4 to GAMP 5 included: gamp 4 guidelines
While it has been superseded by (released in 2008 and revised in 2022), understanding GAMP 4 is critical for maintaining legacy systems, reviewing historical validation documentation, and understanding the evolutionary shift from rigid compliance models to modern risk-based approaches. GAMP is a technical subcommittee of ISPE
GAMP 4 introduced a categorization system for software to determine the level of validation effort required. This was a precursor to modern risk-based categorization: This led to the release of in 2008,